Craig Bates Email

AVP, Chemical and Drug Product Development . Reata Pharmaceuticals

Current Roles

Employees:
417
Revenue:
$53.6M
About
Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata's two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Reata Pharmaceuticals Address
5320 Legacy Dr
Irving, TX
United States
Reata Pharmaceuticals Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.